Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Solid Tumors × balugrastim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Docetaxel 2 tislelizumab 1 linifanib 1 balugrastim 1 atezolizumab 1 Tiragolumab 1 Radiation 1 Paclitaxel 1 Filgrastim 1 Erlotinib Hydrochloride 1 Diathermy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡